ArticleNeurology international2022

Successful Consolidation/Maintenance Therapy with Single Agent Ibrutinib for Primary CNS Lymphoma after Initial Induction Therapy.

Steven Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.